Intermittent Hypoxia and Hypercapnia Accelerate Atherosclerosis, Partially via Trimethylamine-Oxide
- 1 November 2017
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 57 (5) , 581-588
Abstract
Obstructive sleep apnea (OSA) is a common disorder characterized by intermittent hypoxia and hypercapnia (IHC) during sleep. OSA has been shown to be a risk factor for atherosclerosis, but the relation of IHC to the induction or progression of atherosclerosis is not well understood. To dissect the mechanisms involved, we compared atherosclerotic lesion formation in two mouse models, i.e., apolipoprotein E (ApoE) and low density lipoprotein receptor (Ldlr)–deficient mice, with or without IHC exposure. Ten-week-old ApoE−/− or Ldlr−/− mice were fed a high-fat diet for 4 or 8 weeks while being exposed to IHC for 10 hours/day or room air (RA) for 24 hours/day. En face lesions of the aorta, aortic arch, and pulmonary artery (PA) were examined. Moreover, 3,3-dimethyl-1-butanol (DMB), an inhibitor of microbial trimethylamine (TMA) production, was used to determine the contribution of TMA-oxide (TMAO) to IHC-induced atherosclerosis. Eight weeks of IHC exposure expedited the formation of atherosclerosis in both the PA and aortic arch of ApoE−/− mice, but only in the PA of Ldlr−/− mice (ApoE−/− PA 8 wk, IHC 35.4 ± 1.9% versus RA 8.0 ± 2.8%, P < 0.01). The atherosclerotic lesions evolved faster and to a more severe extent in ApoE−/− mice as compared with Ldlr−/− mice (PA IHC 8 wk, ApoE−/− 35.4 ± 1.9% versus Ldlr−/− 8.2 ± 1.5%, P < 0.01). DMB significantly attenuated but did not totally eliminate IHC-induced PA atherosclerosis. Our findings suggest that IHC, a hallmark of OSA, accelerates the progression of atherosclerosis in the aorta and especially in the PA. This process is partly inhibited by DMB, demonstrating that microbial metabolites may serve as therapeutic targets for OSA-induced atherosclerosis.Keywords
This publication has 48 references indexed in Scilit:
- Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approachHypoxia, 2016
- Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart FailureJACC, 2014
- Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out miceAtherosclerosis, 2011
- Apolipoprotein E Induces Antiinflammatory Phenotype in MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Subendothelial Lipoprotein Retention as the Initiating Process in AtherosclerosisCirculation, 2007
- Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathingSleep and Breathing, 2006
- Inflammatory Aspects of Sleep Apnea and Their Cardiovascular ConsequencesSouthern Medical Journal, 2006
- Early Signs of Atherosclerosis in Obstructive Sleep ApneaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Evidence for Lipid Peroxidation in Obstructive Sleep ApneaSLEEP, 2004
- Chronic hypercapnia inhibits hypoxic pulmonary vascular remodelingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000